Dysfunction of NFE2L1 and other family members causes damage in dopaminergic neuron function through dysregulated transcriptional networks - an attempt to search for candidate drugs for Parkinson's disease using in vitro and in vivo approaches
2022/45/N/NZ5/02443
Keywords
Descriptors
- NZ5_001: Etiologia chorób człowieka
- NZ5_003: Patogeneza chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Genetyki i Hodowli Zwierząt PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 21 – announced on 2022-03-28
- Amount awarded
- 209 995 PLN
- Project start date
- 2023-02-02
- Project end date
- 2027-02-01
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
- Authors:
- Kamila Łuczyńska, Zhengwen Zhang, Tadeusz Pietras, Yiguo Zhang, Hiroaki Taniguchi
- Academic press:
- Redox Biology (year: 2023, volume: 69, pages: 103003), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.redox.2023.103003 – link to the publication